Skip to content
10-Q

Quarterly Report

ABVC BioPharma, Inc. ABVC

0001213900-25-104811

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 24.3M sh
Gross Profit Q3 2025 · Sep 30, 2025 $795.95K
Gross Profit Q3 2025 · Sep 30, 2025 $795.95K
Revenue Q3 2025 · Sep 30, 2025 $795.95K
Revenue Q3 2025 · Sep 30, 2025 $795.95K